Home›Cyp3a Inducers›Cyp3a Inducers + Olanzapine And Samidorphan L Malate

Does Cyp3a Inducers Interact with Olanzapine And Samidorphan L Malate?

Cyp3a Inducers and Olanzapine And Samidorphan L Malate have a major drug interaction according to U.S. FDA drug labeling data. Coadministration decreases AUC and Cmax of olanzapine and samidorphan, which may reduce LYBALVI efficacy. Concomitant use is not recommended. The mechanism involves cyp3a4-mediated induction decreasing drug exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Olanzapine And Samidorphan L Malate Class
Atypical Antipsychotic
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Cyp3a Inducers and Olanzapine And Samidorphan L Malate occurs because cyp3a4-mediated induction decreasing drug exposure. Clinically, this means coadministration decreases auc and cmax of olanzapine and samidorphan, which may reduce lybalvi efficacy. concomitant use is not recommended. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Cyp3a Inducers and your doctor is considering prescribing Olanzapine And Samidorphan L Malate (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Cyp3a Inducers+💊 Olanzapine And Samidorphan L Malate(Lybalvi)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
—
Drug B class
Atypical Antipsychotic
Source
NLP:olanzapine and samidorphan l-malate

What this means in plain English

Coadministration decreases AUC and Cmax of olanzapine and samidorphan, which may reduce LYBALVI efficacy. Concomitant use is not recommended.

What the FDA label says

"CYP3A4-mediated induction decreasing drug exposure"

📖 Source: NLP:olanzapine and samidorphan l-malate

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Cyp3a Inducers and Olanzapine And Samidorphan L Malate against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.